When a pharmacy fills a prescription with a generic equivalent, the medication is supposed to be functionally equivalent to the brand-name counterparts, and in most respects they are. However, following a Supreme Court decision last year, manufacturers of generic drugs may not be held liable through… Read More
By Austin Kirk
March 26, 2012 | 1 Comment
Australian doctors indicate that a new treatment for women in premature labor could significantly cut down on the risk of cerebral palsy, which is a medical disorder affecting movement control and muscle coordination. It is a chronic motor disability in children, which is commonly associated with… Read More
By Donald Saiontz
March 21, 2012 | No Comments
More than a month after we first noted that Propecia.com, a marketing website previously maintained by Merck for their blockbuster hair loss drug, was "not currently available", the domain continues to display a place-holder page and men continue to face a risk of sexual complications as… Read More
By Harvey Kirk
March 19, 2012 | No Comments
The product liability lawyers at Saiontz & Kirk continue to review potential metal-on-metal hip replacement lawsuits for individuals throughout the United States. Although most of the media attention has been focused on the recalled DePuy ASR hip implant, all metal-on-metal systems have the potential to cause… Read More
By Austin Kirk
March 12, 2012 | 1 Comment
The longer diabetes patients use Actos, ActoPlus Met or Duetact, the greater their risk of developing bladder cancer may be. However, many users of these popular medications remain unaware or confused about the link between Actos and bladder cancer. (more…) Read More
By Harvey Kirk
March 9, 2012 | No Comments
More than 11,300 people throughout the United States have filed a Yaz lawsuit, Yasmin lawsuit, Ocella lawsuit or Gianvi lawsuit against Bayer after suffering a blood clot or other injury that was caused by one of the popular birth control pills, and that number is expected… Read More
By Harvey Kirk
March 2, 2012 | No Comments
Pradaxa (dabigatran) is a relatively new blood thinner, which was just introduced in October 2010 as a replacement for Coumadin (warfarin). However, in the short period of time the drug has been on the market, an alarming number of deaths and serious bleeds have occurred from… Read More
By Austin Kirk
February 29, 2012 | 1 Comment
Two recent studies highlight the dramatic effects children can suffer from a traumatic brain injury, which could occur as a result of an automobile accident, trip and fall or any other incident in which the child suffers a head trauma. ▸ Traumatic Brain Injury Lawsuits (more…) Read More
By Donald Saiontz
February 21, 2012 | No Comments
For over three and a half years, the lawyers at Saiontz & Kirk have been reviewing potential claims for individuals who may be entitled to financial compensation through a lawsuit for NuvaRing health problems. In recent months, the number of lawyer television advertisements for these cases… Read More
By Harvey Kirk
February 17, 2012 | No Comments
Although Boehringer Ingelheim, the maker of the new blood thinner Pradaxa, has attempted to suggest that the number of individuals who have experienced severe bleeding on their medication is in-line with other blood thinners, a recent report from a drug watchdog group highlights how serious and… Read More
By Austin Kirk
February 13, 2012 | No Comments